Who Paid My Doc
Jaideep Mehta
Pain Medicine Houston, TX Medical Doctor
NPI 1841459021 CMS profile 83988
1140 Business Center Dr Ste 110, Houston, TX 77043
General payments
$134,044
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$27,115
Through program year 2022, Jaideep Mehta of Houston, TX is reported in the CMS Open Payments database as having received $134,044 across 477 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $27,115 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 98th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $22,473 | 65 | |
| 2021 | General | $98,769 | 270 | |
| 2020 | General | $6,522 | 99 | |
| 2019 | General | $6,279 | 43 |
Beside peers
- Jaideep Mehta
- Pain Medicine median
- Middle half of Pain Medicine
- National median
In program year 2025, general payments to Jaideep Mehta were reported at $0. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.
Show as a table
| Year | Jaideep Mehta | Pain Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $6,279 | $498 | $126–$1,682 | $163 |
| 2020 | $6,522 | $284 | $80–$910 | $114 |
| 2021 | $98,769 | $399 | $112–$1,219 | $132 |
| 2022 | $22,473 | $455 | $137–$1,484 | $149 |
| 2023 | $0 | $484 | $128–$1,495 | $160 |
| 2024 | $0 | $498 | $131–$1,540 | $164 |
| 2025 | $0 | $458 | $124–$1,401 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
477 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pain Medicine in Texas
Related records
Pain Medicine in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Pain Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.